These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6171127)
21. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice. Gemmell E; Sernia C; Grieco DA; Bird PS; Allen CJ; Seymour GJ Oral Microbiol Immunol; 2001 Jun; 16(3):129-35. PubMed ID: 11358534 [TBL] [Abstract][Full Text] [Related]
22. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706 [TBL] [Abstract][Full Text] [Related]
23. [Use of monoclonal antibodies for the production of a plague antibody erythrocyte diagnostic agent]. Kanatov IuV; Levi MI; Shmuter MF; Men'shov PI; Temiralieva GA Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):73-8. PubMed ID: 3904286 [TBL] [Abstract][Full Text] [Related]
24. [The effect of different Yersinia pestis antigens on the cellular link in immunity]. Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408 [TBL] [Abstract][Full Text] [Related]
25. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction 1-specific antibody response. Thomas RE; Simpson WJ; Perry LL; Schwan TG Am J Trop Med Hyg; 1992 Jul; 47(1):92-7. PubMed ID: 1386197 [TBL] [Abstract][Full Text] [Related]
26. [Comparative incidence of detection of specific antibodies to Yersinia pestis capsular antigen and lipopolysaccharide in humans immunized with pest vaccine]. Devdariani ZL; Fedorova VA; Gromova OV; Taranenko TM Klin Lab Diagn; 1997 Apr; (4):39-41. PubMed ID: 9221077 [TBL] [Abstract][Full Text] [Related]
27. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis. Weeks S; Hill J; Friedlander A; Welkos S Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679 [TBL] [Abstract][Full Text] [Related]
28. Development of a double-antibody sandwich ELISA for sensitive detection of Yersinia pestis. Choi SY; Rhie GE; Jeon JH Microbiol Immunol; 2020 Jan; 64(1):72-75. PubMed ID: 31621104 [TBL] [Abstract][Full Text] [Related]
29. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague. Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812 [TBL] [Abstract][Full Text] [Related]
30. [Criterion of the comparative sensitivity of plague antigenic and antibody erythrocyte diagnostica in detecting antibodies]. Filimonova IuA; Oganian EF; Onatskaia TG Lab Delo; 1979; (10):613-6. PubMed ID: 94132 [No Abstract] [Full Text] [Related]
31. [The effect of the Yersinia pestis capsular antigen on the 5'-nucleotidase activity of macrophages from mice of different strains]. Kirillicheva GB; Naumov AV; Taranenko TM; Serdobintsev LN; Solov'eva MS; Baturina IG Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):105-6. PubMed ID: 8079523 [No Abstract] [Full Text] [Related]
32. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Eyles JE; Butcher WA; Titball RW; Hill J Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388 [TBL] [Abstract][Full Text] [Related]
33. Yersinia pestis V protein epitopes recognized by CD4 T cells. Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563 [TBL] [Abstract][Full Text] [Related]
34. [Mathematical modelling of the interaction of the plague capsular antigen with antibodies of varying affinity]. Levi MI Antibiot Med Biotekhnol; 1986 Mar; 31(3):203-9. PubMed ID: 3521467 [TBL] [Abstract][Full Text] [Related]
35. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens]. Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769 [No Abstract] [Full Text] [Related]
36. [Immunogenicity of Yersinia pestis grown on nutrient media at 28 and 37 degrees C]. Sheremet OV; Miliutin VN; Terent'ev AN; Morozova LN Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):63-8. PubMed ID: 3673377 [TBL] [Abstract][Full Text] [Related]
38. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. Green M; Rogers D; Russell P; Stagg AJ; Bell DL; Eley SM; Titball RW; Williamson ED FEMS Immunol Med Microbiol; 1999 Feb; 23(2):107-13. PubMed ID: 10076907 [TBL] [Abstract][Full Text] [Related]
39. Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis. Gemmell E; Winning TA; Carter CL; Ford PJ; Bird PS; Ashman RB; Grieco DA; Seymour GJ Oral Microbiol Immunol; 2003 Dec; 18(6):364-70. PubMed ID: 14622342 [TBL] [Abstract][Full Text] [Related]
40. Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating host immune response, NF-kappaB activation and cell death. Liu T; Agar SL; Sha J; Chopra AK Microb Pathog; 2010 Jan; 48(1):42-52. PubMed ID: 19737605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]